↓ Skip to main content

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care

Overview of attention for article published in Breast Cancer Research and Treatment, October 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
13 X users

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
133 Mendeley
Title
Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care
Published in
Breast Cancer Research and Treatment, October 2016
DOI 10.1007/s10549-016-4003-9
Pubmed ID
Authors

Rossella Graffeo, Luca Livraghi, Olivia Pagani, Aron Goldhirsch, Ann H. Partridge, Judy E. Garber

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 133 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 133 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 24 18%
Student > Ph. D. Student 14 11%
Student > Master 14 11%
Student > Bachelor 13 10%
Other 12 9%
Other 28 21%
Unknown 28 21%
Readers by discipline Count As %
Medicine and Dentistry 49 37%
Biochemistry, Genetics and Molecular Biology 22 17%
Agricultural and Biological Sciences 14 11%
Unspecified 5 4%
Nursing and Health Professions 4 3%
Other 8 6%
Unknown 31 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 November 2016.
All research outputs
#5,240,953
of 25,837,817 outputs
Outputs from Breast Cancer Research and Treatment
#944
of 5,058 outputs
Outputs of similar age
#79,812
of 328,974 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#17
of 76 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,058 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,974 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 76 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.